Public COA audit

Tesamorelin · Ipamorelin

Audited September 5, 2026

Incomplete documentation

Missing panels or key metadata — not enough evidence to treat this as a full certificate.

Legitimacy
45
Confidence
75%
Panels
0/7

Scored poorly because the file is incomplete or not a full COA, limited panel coverage (0/7), 3 critical findings, and notable note: "No analytical panels present". To improve: upload the full certificate (or the matching sibling purity/endotoxin report) and include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
2X+15N042925
Sample date
2025-05-06
Issue date
2025-05-07

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

0 of 7 present · 0 passed · 0 failed · 0 reported · 7 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Not on this certificate file · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Purity

    Not on this certificate file · core

    Reported purity percentage for the analyte.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Not on this certificate file · core

    LAL or chromogenic endotoxin assay.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • No analytical panels present

    This report shows only quantitative mass measurements (mg) for Tesamorelin and Ipamorelin in vials, but provides no identity confirmation (MS, HPLC), no purity analysis, no safety panels (endotoxin, heavy metals, microbial, sterility), and no residual solvent/water testing. This is a vial content assessment, not a comprehensive COA.

  • No purity data

    The report lists mass quantities (11.12 mg, 11.02 mg, 11.08 mg for Tesamorelin; 5.77 mg, 5.78 mg, 5.81 mg for Ipamorelin) but does not provide percentage purity, HPLC chromatograms, or any indication of compound purity.

  • No identity confirmation

    No mass spectrometry, HPLC retention time, or other identity verification method is documented. The report assumes the compounds are what the client labeled them as, without independent confirmation.

  • Known testing lab with verification

    Janoshik is a recognized peptide testing laboratory. The report includes a verification URL (www.janoshik.com/verify/) and unique key (QE6XP2T6H62K) for authenticity checking.

  • Batch number present

    Batch/lot number 2X+15N042925 is clearly stated.

  • Dates are consistent and valid

    Testing ordered 02 MAY 2025, sample received 06 MAY 2025, analysis conducted 07 MAY 2025. All dates are sequential, logical, and on or before the current date (2026-09-05).

  • Minimal report scope

    This appears to be a basic quantitative assessment report rather than a full Certificate of Analysis. The test requested was 'Assessment of a peptide vial or vials' which suggests limited scope by design, but this does not meet typical COA standards for research peptides.

Timing & next steps

Practical follow-ups based on document age and gaps.

  • coa age

    This COA was issued over a year ago (486 days) — consider whether a retest is warranted for this batch.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.